Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income Countries Useful? Examples from the World of Vaccines”

Overview of attention for article published in PharmacoEconomics, November 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 8 Mendeley

So far, Altmetric has seen 1 X post from an account with 721 followers.

#HealthEconJA Authors’ Reply to Gandjour: “Are Current Cost-Effectiveness Thresholds for Low- and Middle-Income ... http://t.co/r4OI250hVQ

Reply Repost Favourite